Skip to main content
Top
Published in: International Cancer Conference Journal 1/2019

01-01-2019 | Case report

Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment

Authors: Yuzuru Sakamoto, Toshiya Kamiyama, Hideki Yokoo, Shingo Shimada, Takahiro Einama, Kenji Wakayama, Tatsuya Orimo, Hirofumi Kamachi, Tomoaki Naka, Tomoko Mitsuhashi, Akinobu Taketomi

Published in: International Cancer Conference Journal | Issue 1/2019

Login to get access

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a naturally occurring glycoprotein that is synthesized by stromal cells in bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but it is extremely rare in hepatocellular carcinoma (HCC). Here, we report a rare case of HCC producing G-CSF. The patient presented with a continuous fever and had a huge liver mass in the right lobe with portal vein tumor thrombus (PVTT) in the right first branch. He had marked granulocytosis, and his serum level of G-CSF was elevated. A complete curative liver resection was performed after preoperative radiotherapy to PVTT. The pathological findings of the resected specimen revealed poorly/moderately differentiated HCC, and immunohistochemical staining of G-CSF was negative the first time it was tested, but the second time, it was positive in the cytoplasm of other tumor cells of HCC. Only a few cases of G-CSF-producing HCC have been reported, and they resulted in rapid tumor growth, metastases, and poor prognosis. In our case with PVTT, there was no liver recurrence, although multiple lung metastases occurred at 8 months after curative resection. We should consider G-CSF-producing HCC and diagnose promptly when encountering liver tumor patients with leukocytosis, and we should perform multimodal treatment including radiation, radical surgery, and chemotherapy.
Literature
1.
go back to reference Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35CrossRefPubMed Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35CrossRefPubMed
2.
go back to reference Asano S, Urabe A, Okabe T et al (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 49:845–852PubMed Asano S, Urabe A, Okabe T et al (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 49:845–852PubMed
3.
go back to reference Iwasa K, Noguchi M, Mor K et al (1995) Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today 25:158–160CrossRefPubMed Iwasa K, Noguchi M, Mor K et al (1995) Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today 25:158–160CrossRefPubMed
4.
go back to reference Ito N, Matsuda T, Kakehi Y et al (1990) Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323:1709–1710PubMed Ito N, Matsuda T, Kakehi Y et al (1990) Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323:1709–1710PubMed
5.
go back to reference Furihata M, Sonobe H, Ohtsuki Y et al (1999) An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma. Pathol Int 49:1010–1013CrossRefPubMed Furihata M, Sonobe H, Ohtsuki Y et al (1999) An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma. Pathol Int 49:1010–1013CrossRefPubMed
6.
go back to reference Endo K, Kohnoe S, Okamura T et al (2005) Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 8:173–177CrossRefPubMed Endo K, Kohnoe S, Okamura T et al (2005) Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 8:173–177CrossRefPubMed
7.
go back to reference Kamiyama T, Nakanishi K, Yokoo H et al (2007) Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 12:363–368CrossRefPubMed Kamiyama T, Nakanishi K, Yokoo H et al (2007) Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 12:363–368CrossRefPubMed
8.
go back to reference Ueno M, Seferynska I, Beckman B et al (1989) Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257:C743–C749CrossRefPubMed Ueno M, Seferynska I, Beckman B et al (1989) Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257:C743–C749CrossRefPubMed
9.
go back to reference Tani K, Ozawa K, Ogura H et al (1990) Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 3:325–331CrossRefPubMed Tani K, Ozawa K, Ogura H et al (1990) Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 3:325–331CrossRefPubMed
10.
go back to reference Aita K, Seki K (2006) Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 56:413–419CrossRefPubMed Aita K, Seki K (2006) Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 56:413–419CrossRefPubMed
11.
go back to reference Joshita S, Nakazawa K, Koike S et al (2010) A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci 25:476–480CrossRefPubMedPubMedCentral Joshita S, Nakazawa K, Koike S et al (2010) A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci 25:476–480CrossRefPubMedPubMedCentral
12.
go back to reference Berdel WE, Danhauser-Riedl S, Steinhauser G et al (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80–83PubMed Berdel WE, Danhauser-Riedl S, Steinhauser G et al (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80–83PubMed
13.
go back to reference Yamamoto S, Takashima S, Ogawa H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol 34:640–644CrossRefPubMed Yamamoto S, Takashima S, Ogawa H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol 34:640–644CrossRefPubMed
14.
go back to reference Ito T, Okubo K, Shiomi M et al (2012) [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur–uracil.]. Nihon Shokakibyo Gakkai Zasshi 109:2088–2096PubMed Ito T, Okubo K, Shiomi M et al (2012) [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur–uracil.]. Nihon Shokakibyo Gakkai Zasshi 109:2088–2096PubMed
15.
go back to reference Amano H, Itamoto T, Emoto K et al (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159CrossRefPubMed Amano H, Itamoto T, Emoto K et al (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159CrossRefPubMed
16.
go back to reference Araki K, Kishihara F, Takahashi K et al (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27:716–721CrossRefPubMed Araki K, Kishihara F, Takahashi K et al (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27:716–721CrossRefPubMed
17.
go back to reference Kohno M, Shirabe K, Mano Y et al (2013) Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today 43:439–445CrossRefPubMed Kohno M, Shirabe K, Mano Y et al (2013) Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today 43:439–445CrossRefPubMed
18.
go back to reference Snyder RA, Liu E, Merchant NB (2012) Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg 78:821–822PubMed Snyder RA, Liu E, Merchant NB (2012) Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg 78:821–822PubMed
19.
go back to reference Nagata H, Komatsu S, Takaki W et al (2016) Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol 7:380–386CrossRefPubMedPubMedCentral Nagata H, Komatsu S, Takaki W et al (2016) Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol 7:380–386CrossRefPubMedPubMedCentral
Metadata
Title
Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment
Authors
Yuzuru Sakamoto
Toshiya Kamiyama
Hideki Yokoo
Shingo Shimada
Takahiro Einama
Kenji Wakayama
Tatsuya Orimo
Hirofumi Kamachi
Tomoaki Naka
Tomoko Mitsuhashi
Akinobu Taketomi
Publication date
01-01-2019
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 1/2019
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0346-x

Other articles of this Issue 1/2019

International Cancer Conference Journal 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine